Postmarketing adverse drug reactions A duty to report?

Eran Klein, Dennis Bourdette

Research output: Contribution to journal › Article

11 Citations (Scopus)

Abstract

Physicians play an important role in recognizing and reporting suspected adverse drug reactions (ADRs) to the Food and Drug Administration (FDA). Physicians can report suspected ADRs directly to the FDA via its MedWatch program, by contacting the manufacturer of the drug, and by publishing case reports. While this takes time, physicians have an ethical obligation to participate in recognizing and reporting ADR.

Original languageEnglish (US)
Pages (from-to)288-294
Number of pages7
JournalNeurology: Clinical Practice
Volume3
Issue number4
DOIs
StatePublished - Aug 2013

Fingerprint

Drug-Related Side Effects and Adverse Reactions
United States Food and Drug Administration
Physicians
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Postmarketing adverse drug reactions A duty to report? / Klein, Eran; Bourdette, Dennis.

In: Neurology: Clinical Practice, Vol. 3, No. 4, 08.2013, p. 288-294.

Research output: Contribution to journal › Article

Klein, E & Bourdette, D 2013, 'Postmarketing adverse drug reactions A duty to report?', Neurology: Clinical Practice, vol. 3, no. 4, pp. 288-294. https://doi.org/10.1212/CPJ.0b013e3182a1b9f0
Klein E, Bourdette D. Postmarketing adverse drug reactions A duty to report? Neurology: Clinical Practice. 2013 Aug;3(4):288-294. https://doi.org/10.1212/CPJ.0b013e3182a1b9f0
Klein, Eran ; Bourdette, Dennis. / Postmarketing adverse drug reactions A duty to report?. In: Neurology: Clinical Practice. 2013 ; Vol. 3, No. 4. pp. 288-294.
@article{848efa2e4e5e449d8c4e242d810c2688,
title = "Postmarketing adverse drug reactions A duty to report?",
abstract = "Physicians play an important role in recognizing and reporting suspected adverse drug reactions (ADRs) to the Food and Drug Administration (FDA). Physicians can report suspected ADRs directly to the FDA via its MedWatch program, by contacting the manufacturer of the drug, and by publishing case reports. While this takes time, physicians have an ethical obligation to participate in recognizing and reporting ADR.",
author = "Eran Klein and Dennis Bourdette",
year = "2013",
month = "8",
doi = "10.1212/CPJ.0b013e3182a1b9f0",
language = "English (US)",
volume = "3",
pages = "288--294",
journal = "Neurology: Clinical Practice",
issn = "2163-0402",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Postmarketing adverse drug reactions A duty to report?

AU - Klein, Eran

AU - Bourdette, Dennis

PY - 2013/8

Y1 - 2013/8

N2 - Physicians play an important role in recognizing and reporting suspected adverse drug reactions (ADRs) to the Food and Drug Administration (FDA). Physicians can report suspected ADRs directly to the FDA via its MedWatch program, by contacting the manufacturer of the drug, and by publishing case reports. While this takes time, physicians have an ethical obligation to participate in recognizing and reporting ADR.

AB - Physicians play an important role in recognizing and reporting suspected adverse drug reactions (ADRs) to the Food and Drug Administration (FDA). Physicians can report suspected ADRs directly to the FDA via its MedWatch program, by contacting the manufacturer of the drug, and by publishing case reports. While this takes time, physicians have an ethical obligation to participate in recognizing and reporting ADR.

UR - http://www.scopus.com/inward/record.url?scp=84887962823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887962823&partnerID=8YFLogxK

U2 - 10.1212/CPJ.0b013e3182a1b9f0

DO - 10.1212/CPJ.0b013e3182a1b9f0

M3 - Article

AN - SCOPUS:84887962823

VL - 3

SP - 288

EP - 294

JO - Neurology: Clinical Practice

JF - Neurology: Clinical Practice

SN - 2163-0402

IS - 4

ER -

Access to Document